Dow Chemical Company v. Nova Chemicals Corporation, 2017 FC 759

CourtFederal Court
Case DateAugust 08, 2017
JurisdictionCanada (Federal)
Citations2017 FC 759
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
2 practice notes
  • Nova Chemicals Corporation v. Dow Chemicals Company, 2020 FCA 141
    • Canada
    • Federal Court of Appeal (Canada)
    • September 15, 2020
    ...the judgment of the Federal Court in file T-2051-10 (per Fothergill J.): 2017 FC 350, supplementary reasons 2017 FC 637, reasons on costs 2017 FC 759. [2]  After argument in this Court, the appeal and the cross-appeal were held in abeyance for a considerable time to allow for settlement dis......
  • Seedlings Life Science Ventures, LLC v. Pfizer Canada ULC, 2020 FC 505
    • Canada
    • Canada (Federal) Federal Court
    • April 9, 2020
    ...fees are of the same order of magnitude as those incurred in other patent cases such as Dow Chemical Company v Nova Chemicals Corporation, 2017 FC 759, and Apotex Inc v Shire LLC, 2018 FC 1106 [Shire]. [18]  However, Pfizer also seeks costs for its legal fees incurred in January 2020, after......
2 cases
  • Nova Chemicals Corporation v. Dow Chemicals Company, 2020 FCA 141
    • Canada
    • Federal Court of Appeal (Canada)
    • September 15, 2020
    ...the judgment of the Federal Court in file T-2051-10 (per Fothergill J.): 2017 FC 350, supplementary reasons 2017 FC 637, reasons on costs 2017 FC 759. [2]  After argument in this Court, the appeal and the cross-appeal were held in abeyance for a considerable time to allow for settlement dis......
  • Seedlings Life Science Ventures, LLC v. Pfizer Canada ULC, 2020 FC 505
    • Canada
    • Canada (Federal) Federal Court
    • April 9, 2020
    ...fees are of the same order of magnitude as those incurred in other patent cases such as Dow Chemical Company v Nova Chemicals Corporation, 2017 FC 759, and Apotex Inc v Shire LLC, 2018 FC 1106 [Shire]. [18]  However, Pfizer also seeks costs for its legal fees incurred in January 2020, after......